Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019…
Read More
Can biomaterials offer novel therapeutic strategies against COVID-19?
The global coronavirus disease 2019 (COVID-19) pandemic rages on. To date, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected over 138.3 million and caused over 2.9 million deaths the world over. Despite major gains…
Read More
With giant swabs and grumpy camels, Kenya hunts for next deadly virus
Kicking and grunting under the restraint of three men, the camel makes its displeasure known as Kenyan veterinarian Nelson Kipchirchir swirls a giant swab in the nostril of the grumpy dromedary. It turns out camels don’t much like being tested…
Read More
Experimental evidence that ADAM17 inhibition prevents severe COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus that is contagious in humans. It is the causal agent of the ongoing coronavirus 2019 (COVID-19) pandemic. This virus causes a mild to severe infection and has…
Read More
Researchers identify SARS-CoV-2 antiviral compounds using protein assay
On March 11, 2020, the World Health Organization (WHO) announced the coronavirus disease 2019 (COVID-19) to be a pandemic. COVID-19 is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, which is deemed to be highly contagious…
Read More
New test better detects reservoir of virus in HIV patients
A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease. Currently no cure exists for…
Read More
Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants
A new monoclonal antibody targets a particular region of the receptor-binding domain (RBD) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This region is usually not accessible to immune cells, which may be why it has broad neutralizing capabilities….
Read More
No region in the world spared as virus cases, deaths surge
Hospitals in Turkey and Poland are filling up fast. Pakistan is restricting domestic travel to bring a surge in coronavirus infections under control. Even Thailand, which has weathered the coronavirus pandemic far better than many nations, is now struggling to…
Read More
For this hospice nurse, the Covid shot came too late
Antonio Espinoza loved the Los Angeles Dodgers. He loved them so much that he was laid to rest in his favorite Dodgers jersey. His family and friends, including his 3-year-old son, donned a sea of blue-and-white baseball shirts and caps…
Read More
Dramática baja de enfermedades por virus comunes, ¿significa máscaras para siempre?
Las máscaras y el distanciamiento físico están demostrando tener importantes beneficios extra, evitando que las personas contraigan todo tipo de enfermedades, no solo covid-19. Pero no está claro si los protocolos valdrán la pena a largo plazo. Maestros de la…
Read More